Durata Therapeutics (DRTX) Sees IPO Price of $11 - $13/Share

Durata Therapeutics (Nasdaq: DRTX) filed an amended registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The Company plans to offer 6,250,000 shares of Common Stock and sees an offering price of $11 to $13 per share. Durata plans to list on the Nasdaq Global Market under the ticker, "DRTX."

The offering is being made through BofA Merrill Lynch, Credit Suisse, RBC Capital Markets, and Wedbush PacGrow Life Sciences.

Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Southern Cross Acquisition II closes $76.5M IPO on Nasdaq
• Energy Fuels completes acquisition of ASM, gaining rare earth metals plant
• AiRWA receives Nasdaq deficiency notice over late 10-K filing